Profile
Dr. Horacio Plotkin, MD, is Chief Medical Officer at Retrophin, Inc.
He received his doctorate degree from Universidad de Buenos Aires.
Former positions of Horacio Plotkin
| Companies | Position | End |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 29/02/2020 |
| TRAVERE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/01/2016 |
Training of Horacio Plotkin
| Universidad de Buenos Aires | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Stock Market
- Insiders
- Horacio Plotkin
